IL-38对实验性自身免疫性葡萄膜炎的治疗作用:免疫细胞图谱重编程与Th17细胞致病性降低
该研究在小鼠实验性自身免疫性葡萄膜炎(EAU)模型中给予IL-38治疗,发现其减轻EAU症状并降低视网膜和颈部引流淋巴结中Th17与Th1细胞比例;单细胞RNA测序显示IL-38下调IL-17信号通路及Th17致病相关基因Csf2和Il23r,体外实验提示IL-38可能通过抑制Th17细胞与抗原提呈细胞间的GM-CSF/IL-23R/IL-23反馈环路发挥作用。
要点
- IL-38减轻EAU小鼠症状,降低视网膜和颈部引流淋巴结中Th17与Th1细胞比例。
- 单细胞RNA测序显示IL-38下调IL-17信号通路及Th17致病相关基因Csf2和Il23r。
- 体外实验提示IL-38可能通过抑制Th17细胞与抗原提呈细胞间的GM-CSF/IL-23R/IL-23反馈环路发挥作用。
核心结论
- 数据表明IL-38对EAU具有治疗作用,并提示其作用可能由抑制Th17细胞与抗原提呈细胞间的GM-CSF/IL-23R/IL-23反馈环路所致。
研究设计与样本
- 研究对EAU小鼠给予IL-38治疗,采用流式细胞术分析视网膜和颈部引流淋巴结,并对正常、EAU及IL-38治疗小鼠的颈部引流淋巴结进行单细胞RNA测序。
主要发现
- 给予IL-38减轻EAU症状,并降低视网膜和颈部引流淋巴结中Th17与Th1细胞比例。
- 单细胞RNA测序分析中,IL-38下调IL-17信号通路并降低Th17细胞致病相关基因Csf2和Il23r表达,流式细胞术亦证实该结果。
- 体外实验中,IL-38降低IL-23对粒细胞-巨噬细胞集落刺激因子(GM-CSF)的刺激功能,并抑制Th17细胞中IL-23R表达。
- Th17细胞与抗原提呈细胞共培养时,IL-38阻止抗原提呈细胞产生IL-23。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The purpose of this study was to elucidate the effects of interleukin (IL)-38 on experimental autoimmune uveitis (EAU) and its underlying mechanisms. METHODS: Mice with EAU were treated with IL-38, and the retinas and cervical draining lymph nodes (CDLNs) were analyzed by flow cytometry. Single-cell RNA sequencing (scRNA-seq) was conducted to analyze the immune cell profiles of CDLNs from normal, EAU, and IL-38-treated mice. RESULTS: Administration of IL-38 attenuated EAU symptoms and reduced the proportion of T helper 17 (Th17) and T helper 1 (Th1) cells in the retinas and CDLNs. In scRNA-seq analysis, IL-38 downregulated the IL-17 signaling pathway and reduced the expression of Th17 cell pathogenicity-related genes (Csf2 and Il23r), findings which were also confirmed by flow cytometry. In vitro, IL-38 reduced the granulocyte-macrophage colony-stimulating factor (GM-CSF) stimulation function of IL-23 and inhibited IL-23R expression in Th17 cells. Moreover, when co-cultured with Th17 cells, IL-38 prevented IL-23 production in antigen-presenting cells (APCs). CONCLUSIONS: Our data demonstrate the therapeutic effect of IL-38 on EAU, and suggest that the effect of IL-38 may be caused by dampening of the GM-CSF/IL-23R/IL-23 feedback loop between Th17 cells and APCs.
引用
- Li H, Zhu L, Wang R, et al. Therapeutic Effect of IL-38 on Experimental Autoimmune Uveitis: Reprogrammed Immune Cell Landscape and Reduced Th17 Cell Pathogenicity. Invest Ophthalmol Vis Sci. 2021. PMID: 34967854. doi:10.1167/iovs.62.15.31
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。